Sophia Schedin Weiss,
Primary tabs
JAD profile
Associate Editor
Term Expiration:
12/31/2025
Affiliation(s):
Karolinska Institutet; Department of Neurobiology; Care Sciences and Society; Division of Neurogeriatrics
Areas of Interest:
Alzheimer´s disease, protein glycosylation, APP processing, Abeta, super-resolution microscopy, glycomics
Biography & Research:
Sophia Schedin Weiss, PhD, Associate Professor, is a Group Leader at the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Sweden. Dr. Schedin Weiss obtained her PhD in biochemistry on mechanisms involved in the neurological disorder Niemann-Pick type C disease at Stockholm University in 1998. She received a postdoctoral fellowship at the Swedish University for Agricultural Sciences, Sweden, 1999-2002, where she studied protein-glycan and protein-protein interactions involved in the regulation of serine proteases. She was subsequently awarded a fellowship as Assistant Professor at Uppsala University, where she continued to study the role of protein glycosylation for medically important proteins. Dr. Schedin Weiss moved to Karolinska Institutet in 2010, where her research goal is to elucidate early pathophysiological alterations in Alzheimer disease and other neurodegenerative disorders. This research is crucial for finding novel early biomarkers and understanding early disease mechanisms. Her main research topics are to identify and validate glycan biomarkers, study subcellular mechanisms of neurodegenerative diseases using super-resolution microscopy, and to elucidate the link between protein glycosylation and pathophysiological mechanisms in Alzheimer´s disease.
Site Participation